Records containing: Solid Tumor Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-08-22Preoperative Stereotactic Radiotherapy for Treatment of Spinal Metastases
-
CLINICAL_TRIALS study record update · 2025-08-03An Open-Label Study of Tolododekin Alfa (ANK-101) in Renal Allograft Recipients With Resectable, High-Risk Cutaneous Squamous Cell Carcinoma
-
CLINICAL_TRIALS study record update · 2025-07-15A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2Bio) Gene Therapy (GT) Products
-
CLINICAL_TRIALS study record update · 2025-07-02A Multicenter, Prospective, Non-Interventional Real-World Study of Iparomlimab and Tuvonralimab Injection (QL1706) in the Treatment of Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-06-26Safety and Efficacy of an Arginine-Restricted Diet in Patients With Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-06-25A Dose-escalation, Dose-finding, and Expansion Study of XL495 as a Single Agent and in Combination Therapy in Participants With Locally Advanced or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-05-22Treatment of Patients With Solid Tumor Cancers Via Intermediate-Size Patient Population Expanded Access Investigational New Drug (IND)
-
CLINICAL_TRIALS study record update · 2025-05-08Treatment of Solid Tumors Harboring KRAS Mutation With Imatinib and Trametinib
-
CLINICAL_TRIALS study record update · 2025-04-30A Phase I, First-in-Human, Open-Label, Multicenter Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of a Trispecific PD-1/CTLA-4/ VEGF Antibody GB268 in Participants With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-04-25A Phase I, Open-label, Single-center, Dose-escalation and Dose-finding Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of MPD-1 in Patients With Advanced Solid Tumor
-
CLINICAL_TRIALS study record update · 2025-04-04A Phase I/IIa Trial of AD1208, a Cell Cycle Inhibitor/MASTL Inhibitor, as a Single Agent or a Combination in Subjects With Any Progressive, Locally Advanced(Unresectable) or Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-03-19A Phase I Open-label Dose-finding Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of LXP1788 Injection in Patients with Advanced Solid Tumors.
-
CLINICAL_TRIALS study record update · 2025-03-17Neoadjuvant Exercise Therapy in Solid Tumors: A Phase 1b Dose Expansion Trial
-
CLINICAL_TRIALS study record update · 2024-11-29Phase I Clinical Study of Irinotecan Liposomes in Combination with Temozolomide and Vincristine in the Treatment of Patients with Relapsed/refractory Pediatric Solid Tumors
-
CLINICAL_TRIALS study record update · 2024-10-18A Multi-cohort, Open-label, Multi-center Exploratory Study of Efbemalenograstim Alfa Injection for Preventing Absolute Neutrophil Count (ANC) Reduction in Solid Tumor Patients Undergoing Immune-chemotherapy Regimen.
-
CLINICAL_TRIALS study record update · 2024-10-03Multi Omics and Spatial Atlas In Cancer
-
CLINICAL_TRIALS study record update · 2023-12-05Pilot Trial of Written Exposure Intervention for Metastatic Cancer Patients: The EASE Study
-
CLINICAL_TRIALS study record update · 2017-05-30A Study to Determine the Bioequivalence of an Oral Formulation of Topotecan Containing the Drug Substance Manufactured by New Process Relative to the Current Study Formulation of Topotecan in Patients With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-04-17A Study of Single Dose Intravenous Casopitant in Combination With Ondansetron and Dexamethasone for the Prevention of Cisplatin-Induced Nausea and Vomiting
-
CLINICAL_TRIALS study record update · 2014-04-04ClinicalTrials.gov study NCT02103920
-
CLINICAL_TRIALS study record update · 2008-10-16A Phase I, Dose Escalation Study to Assess the Safety and Pharmacokinetics of SB- 485232 Administered as Daily Subcutaneous Injections in Adult Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2008-10-16A Phase I Study to Determine the Safety and Pharmacokinetics of Intravenous Administration of SB743921 on a Once Every 3 Week Schedule in Patients With Solid Tumors
-
CLINICAL_TRIALS study record update · 2008-10-16A Phase I, Open-Label, Dose-Escalation Study of the Safety and Tolerability of Ispinesib in Combination With Capecitabine on an Every 21-Day Schedule in Subjects With Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2008-10-16A Phase I, Open-Label Study of SB-715992 in Combination With Docetaxel in Patients With Advanced Solid Tumors.
-
CLINICAL_TRIALS study record update · 2008-10-13A Phase I, Dose-Escalation Study to Assess the Safety and Pharmacokinetics of SB- 485232 Administered as Five Daily Intravenous Infusions Repeated Every 28 Days in Adult Patients With Solid Tumors and Lymphomas